Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease

Zhang, Huiqin, Wei, Wei, Zhao, Ming, Ma, Lina, Jiang, Xuefan, Pei, Hui, Cao, Yu, Li, Hao·2021·International Journal of Biological Sciences

Cited by (685)

Items 101–200 of 685

  1. Immunotherapy for Parkinson’s Disease and Alzheimer’s Disease: A Promising Disease-Modifying Therapy
    Anns Mahboob, Hasan Ali, Al Jazi Al Naimi, Mahmoud Yousef, Mlaak Rob, Nawaf Ahmad Al-Muhannadi, Degiri Kalana Lasanga Senevirathne, Ali Châari · 2024 · Cells
  2. Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders
    Shailendra Kumar Saxena, Saniya Ansari, Vimal K. Maurya, Swatantra Kumar, Deepak Kumar Sharma, HardeepSingh Malhotra, Sneham Tiwari, Chhitij Srivastava, Janusz Tadeusz Paweska, Ahmed Sayed Abdel-Moneim et al. · 2024 · ACS Pharmacology & Translational Science
  3. Mitochondrial Iron Handling and Lipid Peroxidation as Drivers of Ferroptosis
    José Luis Bucarey, Mariana Casas, Alejandra Espinosa · 2026 · International Journal of Molecular Sciences
  4. Andrographolide exerts a neuroprotective effect by regulating the LRP1-mediated PPARγ/NF-κB pathway
    Yue Ju, Lili Gu, Min Shan Hu, Miao Zheng, Xuebin Zhou, Qin Li, Xinyue Zhang · 2023 · European Journal of Pharmacology
  5. Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
    Degiri Kalana Lasanga Senevirathne, Anns Mahboob, Kevin Zhai, Pradipta Paul, Alexandra Kammen, Darrin Jason Lee, Mohammad S. Yousef, Ali Châari · 2023 · Cells
  6. Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach
    Flora Affuso, Filomena Micillo, Sergio Fazio · 2024 · Biomedicines
  7. Nutrition: A non‐negligible factor in the pathogenesis and treatment of Alzheimer's disease
    Boye Wen, Xiaodong Han, Jin Gong, Pin Wang, Wenxian Sun, Chang Xu, Aidi Shan, Xin Wang, Heya Luan, Shaoqi Li et al. · 2025 · Alzheimer s & Dementia
  8. Divergent actions of physiological and pathological amyloid-β on synapses in live human brain slice cultures
    R. McGeachan, S. Meftah, Lewis W. Taylor, James H. Catterson, Danilo Negro, Calum Bonthron, K. Holt, J. Tulloch, J. Rose, Francesco Gobbo et al. · 2025 · Nature Communications
  9. Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase
    Ai Sze Wee, Thao Dinh Nhu, Kooi Yeong Khaw, Kim San Tang, Keng Yoon Yeong · 2022 · Current Neuropharmacology
  10. Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer’s Disease: Systematic Review
    Anastasia M. Bougea, Efthalia Angelopoulou, Efthimios Vasilopoulos, Philippos Gourzis, Sokratis G. Papageorgiou · 2024 · International Journal of Molecular Sciences
  11. Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
    Mohammed Alrouji, Mohammed S. Alshammari, Tasqeeruddin Syed, Anas Shamsi · 2025 · Antioxidants
  12. Neuroprotective Mechanisms of Salidroside in Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies
    Nan Zhang, Jianfei Nao, Xiaoyu Dong · 2023 · Journal of Agricultural and Food Chemistry
  13. TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer’s disease
    Yiheng Zhao, Qian Guo, Jia Tian, Wei Liu, Xiaochuan Wang · 2024 · Ageing Research Reviews
  14. Electrochemical Biosensors Combined with Nanomaterial Signal Amplification for the Detection of Alzheimer’s Disease Biomarkers in Blood
    Liusi Peng, Xixiang Xie, Xiaoyu Chen, Chunxia Chen · 2025 · ACS Sensors
  15. The Impairment of Blood-Brain Barrier in Alzheimer’s Disease: Challenges and Opportunities with Stem Cells
    Adolfo López-Ornelas, Adriana Jiménez, Gilberto Pérez‐Sánchez, Citlali Ekaterina Rodríguez-Pérez, Alejandro Corzo‐Cruz, Iván Velasco, Enrique Estudillo · 2022 · International Journal of Molecular Sciences
  16. Dual modulators of aggregation and dissociation of amyloid beta and tau: In vitro, in vivo, and in silico studies of Uncaria rhynchophylla and its bioactive components
    Sujin Kim, Yunkwon Nam, Soo Jung Shin, Ritu Prajapati, Seong Min Shin, Minjeong Kim, Hyeon soo Kim, Seol Hwa Leem, Tae‐Jin Kim, Yong‐Ho Park et al. · 2022 · Biomedicine & Pharmacotherapy
  17. The role of transforming growth factor β1 /Smad pathway in Alzheimer’s disease inflammation pathology
    Chunlan Yang, Ping Xu · 2022 · Molecular Biology Reports
  18. Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
    Ning Yan, Fei Xie, Long-Qian Tang, Defeng Wang, Xiang Li, Chao Liu, Zhaopeng Liu · 2023 · Bioorganic Chemistry
  19. Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS
    Weam W. Ibrahim, Rabab Hamed Sayed, Mohamed Fayed Abdelhameed, Enayat Abdel Aziz Omara, Mahmoud I. Nassar, Noha F. Abdelkader, Mohamed Ali Farag, Abdelsamed I. Elshamy, Sherif Mahmoud Afifi · 2024 · Inflammopharmacology
  20. Protein modification in neurodegenerative diseases
    Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, Nasrin Seddigh, Abdollah Allahverdi · 2024 · MedComm
  21. In Vivo Evaluation of Nose-to-Brain Delivery of Liposomal Donepezil, Memantine, and BACE-1 siRNA for Alzheimer’s Disease Therapy
    Lee, David, Shen, Andrew M., Shah, Milin, Garbuzenko, Olga B., Minko, Tamara · 2024 · International Journal of Molecular Sciences
  22. CD2AP deficiency aggravates Alzheimer’s disease phenotypes and pathology through p38 MAPK activation
    Yan‐Yan Xue, Zhe-Sheng Zhang, Rong-Rong Lin, Hui-Fen Huang, Keqing Zhu, Dian-Fu Chen, Zhi‐Ying Wu, Qing‐Qing Tao · 2024 · Translational Neurodegeneration
  23. Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes
    Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, Yi Yang, Suang Lv, Mengrong Miao, Wanming Chen, Szu‐Yuan Wu, Jiaqiang Zhang · 2025 · Diabetes & Metabolism
  24. Serotonergic Regulation in Alzheimer’s Disease
    Л. П. Долгачева, В. П. Зинченко, Alexander D. Nadeev, Nikolay V. Goncharov · 2025 · International Journal of Molecular Sciences
  25. Cryptotanshinone Alleviates Oxidative Stress and Reduces the Level of Abnormally Aggregated Protein in Caenorhabditis elegans AD Models
    Wen-Bo Cui, Zongping Zhang, Xue Bai, Shanshan Wang, Xiaohan Chen, Xu Liu, Pan‐Jie Su, Dejuan Zhi, Dong‐Qing Fei, Zhan‐Xin Zhang et al. · 2022 · International Journal of Molecular Sciences
  26. Cognitive enhancing effects of pazopanib in D‑galactose/ovariectomized Alzheimer’s rat model: insights into the role of RIPK1/RIPK3/MLKL necroptosis signaling pathway
    Rasha Abdelhady, Nancy S. Younis, Omaima Ali, Samah Shehata, Rabab Hamed Sayed, Rania I. Nadeem · 2023 · Inflammopharmacology
  27. Therapeutic Effects of Aβ-Specific Regulatory T Cells in Alzheimer’s Disease: A Study in 5xFAD Mice
    Seon-Young Park, Juwon Yang, Hyejin Yang, Inhee Cho, Jae Yoon Kim, Hyunsu Bae · 2024 · International Journal of Molecular Sciences
  28. Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
    Paloma Mayo, Jorge Pascual-Guerra, Enrique Crisman, Cristina Domínguez, Manuela G. López, Rafael M. Leon · 2024 · Medicinal Research Reviews
  29. Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
    Xia, Zhao-Di, Ma, Ruo-Xin, Wen, Jin-Feng, Zhai, Yu-Fei, Wang, Yu-Qi, Wang, Feng-Yun, Liu, Dan, Zhao, Xiao-Long, Sun, Bao, Jia, Pu et al. · 2023 · Journal of Alzheimer's Disease
  30. Effect of Repetitive Transcranial Magnetic Stimulation on Post-Stroke Comorbid Cognitive Impairment and Depression: A Randomized Controlled Trial
    Kuide Li, Dan Mo, Qian Yu, Rongjian Feng, Yamei Li · 2024 · Journal of Alzheimer s Disease
  31. A Novel Diagnostic Framework with an Optimized Ensemble of Vision Transformers and Convolutional Neural Networks for Enhanced Alzheimer’s Disease Detection in Medical Imaging
    Joy Chakra Bortty, Gouri Shankar Chakraborty, Inshad Rahman Noman, Salil Batra, Joy Das, Kanchon Kumar Bishnu, Md Tanvir Rahman Tarafder, Araf Islam · 2025 · Diagnostics
  32. Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer’s disease
    Hayder Mutter Al-Kuraishy, Ghassan Mohammad Sulaiman, Hamdoon Abdelhamid Mohammed, ‏Hebatallah M. Saad, Ali Ismail Al-Gareeb, Ali K. Albuhadily · 2025 · Inflammopharmacology
  33. Relationship between adult subventricular neurogenesis and Alzheimer’s disease: Pathologic roles and therapeutic implications
    Hyeon Soo Kim, Seong Min Shin, Sujin Kim, Yunkwon Nam, Anji Yoo, M. Moon · 2022 · Frontiers in Aging Neuroscience
  34. Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness
    Seyed Hani Hojjati, Tracy Butler, Gloria Chia-Yi Chiang, Christian Georg Habeck, Arindam RoyChoudhury, Farnia Feiz, Jacob Shteingart, Siddharth Nayak, Sindy Ozoria, Antonio Fernández Guerrero et al. · 2023 · NeuroImage Clinical
  35. Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer’s Disease: A Review
    Rohit Ramesh Doke, Ganesh Lamkhade, Kuldeep Vinchurkar, Sudarshan Kumar Singh · 2024 · ACS Pharmacology & Translational Science
  36. Endoplasmic Reticulum Stress in Neurodegenerative Diseases
    Syed-Abdul-Moiz Hasan, Antonisamy William James, Farzeen M. Fazili, Samiha Tarabishi, Namir M. Sheikh, Zahoor Ahmad Shah · 2024 · Journal of dementia and Alzheimer's disease
  37. Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease
    Mahaveer Singh, Haider Ali, S. Renuka Jyothi, Irwanjot Kaur, Sachin Kumar, Naveen Sharma, G. V. Siva Prasad, Atreyi Pramanik, Waleed Hassan Almalki, Mohd Imran · 2024 · Brain Research
  38. Tau and Amyloid beta causes microglial activation in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Anusree Adithyan, Madhura Chandrashekar, Nagaraj Rangappa · 2025 · Advances in clinical chemistry
  39. Targeting mGluR group III for the treatment of neurodegenerative diseases
    Nadia Rabeh, Baraa Mohammed Hajjar, Jude O. Maraka, Ashwin F. Sammanasunathan, Mohammed Khan, Saif M I Alkhaaldi, Samy Mansour, Rashed T. Almheiri, Hamdan Hamdan, Khaled S. Abd‐Elrahman · 2023 · Biomedicine & Pharmacotherapy
  40. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations
    Xuhua Li, Yujie Chen, Zhiwei Yang, Shengli Zhang, Guanghong Wei, Lei Zhang · 2023 · International Journal of Biological Macromolecules
  41. Ghrelin Induces Ferroptosis Resistance and M2 Polarization of Microglia to Alleviate Neuroinflammation and Cognitive Impairment in Alzheimer’s Disease
    Guo, Yaoxue, Zhao, Junli, Liu, Xing, Lu, Pu, Liang, Furu, Wang, Xueyan, Wu, Jing, Hai, Yan · 2025 · Journal of Neuroimmune Pharmacology
  42. TREM2 in neurodegeneration and diseases
    Abdulkhaliq, Altaf A., Alasiri, Glowi, Kim, Bonglee, Khan, Johra, Ajoolabady, Amir, Yousof, Shimaa Mohammad, Ren, Jun, Tuomilehto, Jaakko, Borai, Anwar, Alrfaei, Bahauddeen M. et al. · 2026 · Molecular Psychiatry
  43. Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset
    Cassandra M Joynes, Murat Bilgel, Yang An, Abhay Moghekar, Nicholas James Ashton, Przemysław Radosław Kac, Thomas K. Karikari, Kaj Blennow, Henrik Zetterberg, Madhav Thambisetty et al. · 2024 · Alzheimer s & Dementia
  44. Advances in research on the pathogenesis and signaling pathways associated with postoperative delirium (Review)
    Weiqing Li, Qin Shi, Runian Bai, Jingzheng Zeng, Lu Lin, Xuemei Dai, Qingqing Huang, Gu Gong · 2025 · Molecular Medicine Reports
  45. Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models
    Zhihui Jin, Yan Lu, Huifang Tang, Huashun Cui · 2025 · Alzheimer s & Dementia
  46. Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets
    Shamseddin Ahmadi, Shiler Khaledi, Kimia Ahmadi, Kambiz Hassanzadeh · 2025 · CNS Neuroscience & Therapeutics
  47. Korean red ginseng polysaccharide as a potential therapeutic agent targeting tau pathology in Alzheimer's disease
    Sujin Kim, Soo Jung Shin, Yunkwon Nam, Yong Ho Park, Byeong‐Hyeon Kim, Hyun Ha Park, Vijay Kumar, Doo‐Han Yoo, Yong Yook Lee, Hyang‐Sook Hoe et al. · 2024 · International Journal of Biological Macromolecules
  48. Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline
    Ali Azargoonjahromi · 2024 · Journal of Pharmacy and Pharmacology
  49. The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
    Julius Mulumba, Rui Duan, Bo Luo, Jiang Wu, Muhammad Sulaiman, Feng Wang, Yong Yang · 2025 · Exploration of neuroscience
  50. Network pharmacology and metabolomics analysis of Tinospora cordifolia reveals BACE1 and MAOB as potential therapeutic targets for neuroprotection in Alzheimer’s disease
    S Amrutha, Chandran Sheela Abhinand, Shubham Sukerndeo Upadhyay, Ravishankar Pervaje, Thottethodi Subrahmanya Keshava Prasad, Prashant Kumar Modi · 2025 · Scientific Reports
  51. Mixed Pathologies and Cognitive Outcomes in Persons Considered for Anti-Amyloid Treatment Eligibility Assessment
    Alifiya Kapasi, Bryan David James, Lei Yu, Ajay Sood, Zoe Arvanitakis, David Alan Bennett, Patricia A. Boyle, Julie A. Schneider · 2025 · Neurology
  52. Aerobic Exercise Facilitates the Nuclear Translocation of SREBP2 by Activating AKT/SEC24D to Contribute Cholesterol Homeostasis for Improving Cognition in APP/PS1 Mice
    Zelin Hu, Yang-Qi Yuan, Zhen Tong, Meiqing Liao, Shunling Yuan, Weijia Wu, Yingzhe Tang, Yirong Wang, Chenhao Tang, Wenfeng Liu · 2023 · International Journal of Molecular Sciences
  53. Exosomes: The endogenous nanomaterials packed with potential for diagnosis and treatment of neurologic disorders
    Xuelin Tang, Yuxuan He, Jinchi Liu, Jingchen Xu, Qiang Peng · 2024 · Colloids and Surfaces B Biointerfaces
  54. Phytochemical and pharmacological properties of the genus Tamarix: a comprehensive review
    Fangjie Li, Wenli Xie, Xianrui Ding, Kuo Xu, Xianjun Fu · 2024 · Archives of Pharmacal Research
  55. The role of exosome-shuttled miRNAs in heavy metal-induced peripheral tissues and neuroinflammation in Alzheimer's disease
    Qing Dong, Huanyong Fu, Hong Jiang · 2024 · Biomedicine & Pharmacotherapy
  56. The role of ferritinophagy and ferroptosis in Alzheimer’s disease
    Ziwen Chen, Nan Zheng, Fuwei Wang, Qiong Zhou, Zihao Chen, Lihua Xie, Qiang Sun, Li Li, Baohong Li · 2024 · Brain Research
  57. Molecular Signaling Pathways of Quercetin in Alzheimer’s Disease: A Promising Arena
    Mansour Abdulaziz Alsaleem, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Mohammed Alrouji, Asmaa S. A. Yassen, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2024 · Cellular and Molecular Neurobiology
  58. The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
    Rajni Daksh, Meby Susan Mathew, Aan Mery Bosco, Christy Sojan, Antriya Annie Tom, Sree Lalitha Bojja, Madhavan Nampoothiri · 2025 · Biochemical and Biophysical Research Communications
  59. The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system
    Tian Li, Haoying He, Ejuan Zhang, Fengjiao Hu, Zhuo Wang, Jian Xu, Mengliu Zeng, Biwen Peng · 2025 · Brain Pathology
  60. CQ-CNN: A lightweight hybrid classical–quantum convolutional neural network for Alzheimer’s disease detection using 3D structural brain MRI
    Mominul Islam, Mohammad Junayed Hasan, M. R. C. Mahdy · 2025 · PLoS ONE
  61. Association between gut microbial dysbiosis and Alzheimer’s disease: an umbrella review
    Sonam Kumari, Varad Desai, Sasidharan Sivakumar, Kriti Sikri, Mohit Kumar · 2025 · npj Dementia
  62. Alzheimer’s disease: Pathophysiology and dental pulp stem cells therapeutic prospects
    Wei Xiong, Ye Liu, Heng Zhou, Shuili Jing, Yan He, Qingsong Ye · 2022 · Frontiers in Cell and Developmental Biology
  63. The role of signaling crosstalk of microglia in hippocampus on progression of ageing and Alzheimer's disease
    He Li, Tianyuan Ye, Xingyang Liu, Rui Guo, Xiuzhao Yang, Yangyi Li, Dongmei Qi, Yihua Wei, Yifan Zhu, Lei Wen et al. · 2023 · Journal of Pharmaceutical Analysis
  64. Studies on the mechanism of Toxoplasma gondii Chinese 1 genotype Wh6 strain causing mice abnormal cognitive behavior
    Qing Tao, Di Yang, Kunpeng Qin, Lei Liu, Mengmeng Jin, Famin Zhang, Jinjin Zhu, Jie Wang, Qingli Luo, Jian Du et al. · 2023 · Parasites & Vectors
  65. Unveiling the multifaceted pathogenesis and therapeutic drugs of Alzheimer's disease: A comprehensive review
    Liting Peng, Zhiming Zhang, Qi Li, Zhenjiang Song, Canqun Yan, Hongyan Ling · 2024 · Heliyon
  66. Drugs repurposing in the experimental models of Alzheimer’s disease
    Sheer A. Joodi, Weam W. Ibrahim, Mahmoud Mohamed Khattab · 2025 · Inflammopharmacology
  67. The Peripheral Amyloid-β Nexus: Connecting Alzheimer’s Disease with Atherosclerosis through Shared Pathophysiological Mechanisms
    Manal M. Khowdiary, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Ahmed A. Elhenawy, Eman K. Rashwan, Athanasios T. Alexiou, Marios Papadakis, Mohammed E. Abo‐El Fetoh, Gaber El‐Saber Batiha · 2025 · NeuroMolecular Medicine
  68. Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer’s Disease
    Qiuzhi Zhou, Weixia Wang, Chunchu Deng · 2025 · Molecular Neurobiology
  69. Tricetin, a Dietary Flavonoid, Alleviates Neuroinflammation and Promotes Autophagy in Alzheimer’s Disease by Regulating the PI3K/Akt/mTOR Signaling Pathway
    Xinyuan Wu, Dan Su, Jiaxin Xu, Ge Ge, Yong‐Zhen Zhang, Bingjian Wu, Kun Hu, Jie Ren, Hao Yang · 2025 · Journal of Agricultural and Food Chemistry
  70. In silico screening of naturally derived dietary compounds as potential butyrylcholinesterase inhibitors for Alzheimer’s disease treatment
    Md. Tarikul Islam, Md. Aktaruzzaman, Chandan Barai, Farhan Ishrak Rafi, Al Riyad Hasan, Tasfiah Tasnim, Parvej Sarder, Ghadeer Mohsen Albadrani, Muath Q. Al‐Ghadi, Amany Ahmed Sayed et al. · 2025 · Scientific Reports
  71. The relationship between increased levels of microbiota-derived lipopolysaccharide in obesity and the pathophysiology of neurodegenerative diseases
    Mahtab Mehboodi, Milad PourMohammadAli Namdari, Zeynab Abdollahi, Zahra Mobarezi, Maedeh Kiani, Forozan Chamani, Hadis Khanbabaie, Saman Rabiei, Mohammad Hasan Maleki, Hamidreza Sanati et al. · 2025 · Microbial Pathogenesis
  72. Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease
    Meshal Alshamrani · 2023 · Antibodies
  73. Influence of Alzheimer's Disease Related Neuropathology on Local Microenvironment Gene Expression in the Human Inferior Temporal Cortex
    Sang Ho Kwon, Sowmya Parthiban, Madhavi Tippani, Heena R. Divecha, Nicholas J. Eagles, Jashandeep S. Lobana, Stephen R. Williams, Michelle Mak, Rahul A. Bharadwaj, Joel E. Kleinman et al. · 2023 · GEN Biotechnology
  74. Treatment with Blackberry Extract and Metformin in Sporadic Alzheimer’s Disease Model: Impact on Memory, Inflammation, Redox Status, Phosphorylated Tau Protein and Insulin Signaling
    Júlia Eisenhardt de Mello, Fernanda Cardoso Teixeira, Alessandra dos Santos, Karina Pereira Luduvico, Mayara Sandrielly Pereira Soares, William Borges Domingues, Vinícius Farias Campos, Rejane Giacomelli Tavares, Augusto Schneider, Francieli Moro Stefanello et al. · 2024 · Molecular Neurobiology
  75. γ‐Secretase Modulator BPN15606 Reduced Aβ42 and Aβ40 and Countered Alzheimer‐Related Pathologies in a Mouse Model of Down Syndrome
    Xu‐Qiao Chen, Ann Becker, Ricardo Albay, Phuong D. Nguyen, Dmitry Karachentsev, Amanda J. Roberts, Kevin D. Rynearson, Rudolph E. Tanzi, William Cary Mobley · 2024 · Annals of Neurology
  76. Neurotrophic factor-α1/carboxypeptidase E controls progression and reversal of Alzheimer's disease pathogenesis in mice
    Fang-Cheng Fan, Liming Liu, Mei Guo, Yang Du, Yuewen Chen, Y. Peng Loh, Yong Cheng · 2025 · Theranostics
  77. Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
    Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, M.M. Rekha, Mayank Kundlas, Pooja Rani, Deepak Nathiya, Kandi Satyam Naidu, Monica Gulati, Manish Ramesh Bhise et al. · 2025 · Neuroscience
  78. Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors
    Amandeep Girdhar, Lin E. Guo · 2022 · Biology
  79. Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
    Suad Hamdan Almasoudi, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Duaa Eliwa, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2025 · Brain Research Bulletin
  80. Astrocyte-driven vasoconstriction impairs glymphatic clearance in a human tauopathy-on-chip model
    Rena Park, Yansong Peng, Aria R. Yslas, Esak Lee · 2025 · APL Bioengineering
  81. From cell death to neurological disease: Unraveling the role of copper
    Qiqi Gao, Yu Chen, Wei Hu, Tong Lou, Fang Yu, Zhenlang Lin, Wei Lin · 2025 · Neurobiology of Disease
  82. ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
    Matthew Paul Lennol, Chiara Bordier, Léana Kamelher, Jason D. Ulrich, David M. Holtzman, Maud Gratuze · 2025 · The Journal of Experimental Medicine
  83. Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer’s Disease and HIV-Associated Neurocognitive Disorders
    George Chigozie Njoku, Georgette D. Kanmogne · 2025 · International Journal of Molecular Sciences
  84. Targeting the glymphatic system: Aβ accumulation and phototherapy strategies across different stages of Alzheimer’s disease
    Danrui Zhao, Junting Wang, Yirui Zhu, Hao Zhang, Chenkang Ni, Zhuowen Zhao, Jingyu Dai, Rongqiao He, Guang-Zhi Liu, Cheng Gan et al. · 2025 · Translational Neurodegeneration
  85. Amyloid-β, Tau, and α-Synuclein Protein Interactomes as Therapeutic Targets in Neurodegenerative Diseases
    D. Mohan Kumar, Priti Talwar · 2025 · Cellular and Molecular Neurobiology
  86. Overexpression of fibroblast growth factor 13 ameliorates amyloid-β-induced neuronal damage
    Hong Zhu, Ruomeng Li, Lan Xiao, Ting Zhang, Dan Ren · 2022 · Neural Regeneration Research
  87. Impact of Peptide Transport and Memory Function in the Brain
    Lihong Cheng, Caiyue Shi, Xixi Li, Toshiro Matsui · 2024 · Nutrients
  88. Novel techniques for early diagnosis and monitoring of Alzheimer’s disease
    Parul Parul, Animesh Kumar Singh, Shubha Shukla · 2024 · Expert Review of Neurotherapeutics
  89. Understanding the Molecular Impact of Physical Exercise on Alzheimer’s Disease
    Alba Cantón-Suárez, Leticia Sánchez-Valdeón, Laura Bello-Corral, Maria Jose Cuevas, Brisamar Estébanez · 2024 · International Journal of Molecular Sciences
  90. The Therapeutic Potential of Glymphatic System Activity to Reduce the Pathogenic Accumulation of Cytotoxic Proteins in Alzheimer’s Disease
    Kamila Kopeć, Dariusz Koziorowski, Stanisław Szlufik · 2025 · International Journal of Molecular Sciences
  91. Tau in Alzheimer's disease: Shaping the future patient journey
    Catherine Jane Mummery, Christopher Chen Li-Hsian, Cristian A. Lasagna‐Reeves, Rik Ossenkoppele, Christopher C. Rowe, Douglas W. Scharre, Huali Wang, Simon Kyaga, Jeffrey L. Cummings · 2026 · The Journal of Prevention of Alzheimer s Disease
  92. Diosmin ameliorates inflammation, apoptosis and activates PI3K/AKT pathway in Alzheimer’s disease rats
    Yanbo Wang, Xiaojun Ye, Wenwen Su, Ci Yan, Haiyan Pan, Xiaowei Wang, Sen Shao · 2024 · Metabolic Brain Disease
  93. Danggui Shaoyao San and disassembled prescription: neuroprotective effects via AMPK/mTOR-mediated autophagy in mice
    Xiaoqing Cheng, Yuqiong Dai, B. Shang, Shuting Zhang, Liting Lin, Qingguang Wu, Ruoting Zhan, Shengqing Li, Sijun Liu · 2024 · BMC Complementary Medicine and Therapies
  94. Glucose Metabolic Abnormality: A Crosstalk between Depression and Alzheimer’s Disease
    Shaobin Yang, Yanhong Li, Qi Tang, Yimeng Zhang, Tingji Shao · 2024 · Current Neuropharmacology
  95. Red-emitting BSA-copper nanocluster probe for sensitive and selective fluorometric determination of memantine HCl: Application to pharmacokinetics monitoring
    Ahmed Serag, Maram H. Abduljabbar, Yusuf S. Althobaiti, Reem M. Alnemari, Farooq M. Almutairi, Muneef M. Aldhafeeri, Atiah H. Almalki · 2024 · Microchemical Journal
  96. Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-β aggregation and mitigates cognitive decline in Alzheimer's disease
    Divya Shastri, Chaitany Jayprakash Raorane, Vinit Raj, Sang-Kil Lee · 2025 · Journal of Controlled Release
  97. Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
    Emma Ortiz-Islas, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, Elizabeth Ruiz-Sánchez, Talía Sánchez-Barbosa, Diego Pichardo-Rojas, Cecilia Zavala‐Tecuapetla, Karla Carvajal, Victoria Campos‐Peña · 2025 · Pharmaceutics
  98. Sleep fragmentation impairs cognitive function and exacerbates Alzheimer's disease-related pathology in a mouse model by disrupting mitochondrial biogenesis
    Shunjie Liu, Xingyi Liu, Man Ke, Jinliang Wang · 2025 · Experimental Neurology
  99. Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
    Sha Sha, Lina Ren, Xiaona Xing, Wanshu Guo, Yan Wang, Ying Li, Yunpeng Cao, Le Qu · 2025 · Neural Regeneration Research
  100. miR ‐6076 targets BCL6 in SH‐SY5Y cells to regulate amyloid‐β‐induced neuronal damage
    Yujian Lin, Lei Zhang, Mengyue Gao, Zixin Tang, Xiang Cheng, Haoming Li, Jianbing Qin, Meiling Tian, Guohua Jin, Xinhua Zhang et al. · 2023 · Journal of Cellular and Molecular Medicine